[费城染色体：从基因到治疗方法] - Suppr

Suppr

超能文献

[The Philadelphia chromosome: from the gene to therapeutic methods].

作者信息

Pérez-Losada J, González-Sarmiento R, Sánchez-García I

机构信息

Departamento de Proliferación y Diferenciación, CSIC, Universidad de Salamanca.

出版信息

Sangre (Barc). 1998 Apr;43(2):127-35.

PMID:9656774

Abstract

摘要

相似文献

[The Philadelphia chromosome: from the gene to therapeutic methods].

Sangre (Barc). 1998 Apr;43(2):127-35.

Molecular biology of chronic myeloid leukemia.

Int J Hematol. 2001 Apr;73(3):308-22. doi: 10.1007/BF02981955.

Cancer genetics. Imprinting in leukaemia.

Nature. 1992 Oct 1;359(6394):362-3. doi: 10.1038/359362a0.

Molecular insights into the Philadelphia translocation.

Hematol Pathol. 1991;5(1):1-10.

The molecular biology of chronic myeloid leukaemia.

Leukemia. 1996 May;10(5):751-6.

[New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].

Orv Hetil. 2004 Dec 26;145(52):2603-9.

Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.

Baillieres Clin Haematol. 1992 Oct;5(4):897-930. doi: 10.1016/s0950-3536(11)80051-x.

ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.

Leukemia. 2002 May;16(5):951-2. doi: 10.1038/sj.leu.2402441.

BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia.

Cancer Res. 2007 Jul 15;67(14):7045-53. doi: 10.1158/0008-5472.CAN-06-4312.

Bcr: a negative regulator of the Bcr-Abl oncoprotein.

Oncogene. 1999 Aug 5;18(31):4416-24. doi: 10.1038/sj.onc.1202828.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

[The Philadelphia chromosome: from the gene to therapeutic methods].

作者信息

Pérez-Losada J, González-Sarmiento R, Sánchez-García I

机构信息

Departamento de Proliferación y Diferenciación, CSIC, Universidad de Salamanca.

出版信息

Sangre (Barc). 1998 Apr;43(2):127-35.

PMID:9656774

Abstract

摘要

相似文献

[The Philadelphia chromosome: from the gene to therapeutic methods].

Sangre (Barc). 1998 Apr;43(2):127-35.

Molecular biology of chronic myeloid leukemia.

Int J Hematol. 2001 Apr;73(3):308-22. doi: 10.1007/BF02981955.

Cancer genetics. Imprinting in leukaemia.

Nature. 1992 Oct 1;359(6394):362-3. doi: 10.1038/359362a0.

Molecular insights into the Philadelphia translocation.

Hematol Pathol. 1991;5(1):1-10.

The molecular biology of chronic myeloid leukaemia.

Leukemia. 1996 May;10(5):751-6.

[New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].

Orv Hetil. 2004 Dec 26;145(52):2603-9.

Philadelphia chromosome-positive leukaemia: the translocated genes and their gene products.

Baillieres Clin Haematol. 1992 Oct;5(4):897-930. doi: 10.1016/s0950-3536(11)80051-x.

ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.

Leukemia. 2002 May;16(5):951-2. doi: 10.1038/sj.leu.2402441.

BCR-tyrosine 177 plays an essential role in Ras and Akt activation and in human hematopoietic progenitor transformation in chronic myelogenous leukemia.

Cancer Res. 2007 Jul 15;67(14):7045-53. doi: 10.1158/0008-5472.CAN-06-4312.

Bcr: a negative regulator of the Bcr-Abl oncoprotein.

Oncogene. 1999 Aug 5;18(31):4416-24. doi: 10.1038/sj.onc.1202828.